Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Amanda Newman

Showing results (11-20 of 29) with videos related to

Pageof 3
Sort By:
Biorxiv : the Preprint Server for Biology|January 3, 2024
Engineering immunogens that select for specific mutations in HIV broadly neutralizing antibodiesRory Henderson, Kara Anasti, Kartik Manne, et al.
Nature Communications|November 3, 2024
Engineering immunogens that select for specific mutations in HIV broadly neutralizing antibodiesRory Henderson, Kara Anasti, Kartik Manne, et al.
Biorxiv : the Preprint Server for Biology|August 17, 2021
Ability of nucleoside-modified mRNA to encode HIV-1 envelope trimer nanoparticlesZekun Mu, Kevin Wiehe, Kevin O Saunders, et al.
Cell Reports|October 20, 2023
Vaccine-mediated protection against Merbecovirus and Sarbecovirus challenge in miceDavid R Martinez, Alexandra Schäfer, Tyler D Gavitt, et al.
Biorxiv : the Preprint Server for Biology|December 23, 2024
Structural and antigenic characterization of novel and diverse Henipavirus glycoproteinsAaron J May, Muralikrishna Lella, Jared Lindenberger, et al.
Journal of Virology|August 13, 2024
Comparison of the immunogenicity of mRNA-encoded and protein HIV-1 Env-ferritin nanoparticle designsZekun Mu, Jill Whitley, Diana Martik, et al.
Cell Reports|March 16, 2022
mRNA-encoded HIV-1 Env trimer ferritin nanoparticles induce monoclonal antibodies that neutralize heterologous HIV-1 isolates in miceZekun Mu, Kevin Wiehe, Kevin O Saunders, et al.
Science Translational Medicine|January 8, 2025
An engineered immunogen activates diverse HIV broadly neutralizing antibody precursors and promotes acquisition of improbable mutationsOlivia M Swanson, Qianyi E Zhang, Elizabeth Van Itallie, et al.
Cell Reports|December 28, 2017
Vaccine Induction of Heterologous Tier 2 HIV-1 Neutralizing Antibodies in Animal ModelsKevin O Saunders, Laurent K Verkoczy, Chuancang Jiang, et al.
Cell Host & Microbe|April 26, 2024
Mutation-guided vaccine design: A process for developing boosting immunogens for HIV broadly neutralizing antibody inductionKevin Wiehe, Kevin O Saunders, Victoria Stalls, et al.
Pageof 3

Showing results (11-20 of 29) with videos related to

Sort By:
Pageof 3
Biorxiv : the Preprint Server for Biology|January 3, 2024
Engineering immunogens that select for specific mutations in HIV broadly neutralizing antibodiesRory Henderson, Kara Anasti, Kartik Manne, et al.
Nature Communications|November 3, 2024
Engineering immunogens that select for specific mutations in HIV broadly neutralizing antibodiesRory Henderson, Kara Anasti, Kartik Manne, et al.
Biorxiv : the Preprint Server for Biology|August 17, 2021
Ability of nucleoside-modified mRNA to encode HIV-1 envelope trimer nanoparticlesZekun Mu, Kevin Wiehe, Kevin O Saunders, et al.
Cell Reports|October 20, 2023
Vaccine-mediated protection against Merbecovirus and Sarbecovirus challenge in miceDavid R Martinez, Alexandra Schäfer, Tyler D Gavitt, et al.
Biorxiv : the Preprint Server for Biology|December 23, 2024
Structural and antigenic characterization of novel and diverse Henipavirus glycoproteinsAaron J May, Muralikrishna Lella, Jared Lindenberger, et al.
Journal of Virology|August 13, 2024
Comparison of the immunogenicity of mRNA-encoded and protein HIV-1 Env-ferritin nanoparticle designsZekun Mu, Jill Whitley, Diana Martik, et al.
Cell Reports|March 16, 2022
mRNA-encoded HIV-1 Env trimer ferritin nanoparticles induce monoclonal antibodies that neutralize heterologous HIV-1 isolates in miceZekun Mu, Kevin Wiehe, Kevin O Saunders, et al.
Science Translational Medicine|January 8, 2025
An engineered immunogen activates diverse HIV broadly neutralizing antibody precursors and promotes acquisition of improbable mutationsOlivia M Swanson, Qianyi E Zhang, Elizabeth Van Itallie, et al.
Cell Reports|December 28, 2017
Vaccine Induction of Heterologous Tier 2 HIV-1 Neutralizing Antibodies in Animal ModelsKevin O Saunders, Laurent K Verkoczy, Chuancang Jiang, et al.
Cell Host & Microbe|April 26, 2024
Mutation-guided vaccine design: A process for developing boosting immunogens for HIV broadly neutralizing antibody inductionKevin Wiehe, Kevin O Saunders, Victoria Stalls, et al.
Pageof 3